Efficacy of Canakinumab as First-Line Biologic Agent in Adult-Onset Still’s Disease

Arthritis Research & Therapy
doi 10.1186/s13075-019-1843-9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Development and Role in Therapy of Canakinumab in Adult-Onset Still’s Disease

Frontiers in Pharmacology
Pharmacology
2018English

Adult Onset Still’s Disease Masquerading as Acute Coronary Syndrome

International Journal of Diagnostic Imaging
2016English

Adult-Onset Still’s Disease Presenting as an Atypical Cutaneous Eruption

SKIN The Journal of Cutaneous Medicine
2019English

Delay in the Diagnosis of Adult-Onset Still’s Disease

Cureus
2017English

Anakinra for the Treatment of Adult-Onset Still’s Disease

Expert Review of Clinical Immunology
AllergyImmunology
2018English

Adult-Onset Still’s Disease Masquerading as Sepsis in an Asplenic Active Duty Soldier

Case Reports in Medicine
Medicine
2012English

Adult-Onset Still’s Disease in an Elderly Woman With Atypical Presentation

Case Reports in Internal Medicine
2014English

Impaired Autophagic Flux and Its Related Inflammation in Patients With Adult-Onset Still’s Disease

Oncotarget
Oncology
2017English

A Case of Refractory Gastric Ulcer Associated With Cytomegalovirus in Adult-Onset Still’s Disease

Progress of Digestive Endoscopy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy